References

¹Weinstock, H., et al. Sexually transmitted diseases among American youth: Incidence and prevalence estimates, 2000. Perspectives on Sexual and Reproductive Health 36(1):6–10, 2004.

²Chesson, H.W., et al. The estimated direct medical cost of sexually transmitted diseases among American youth, 2000. Perspectives on Sexual and Reproductive Health 36(1):11–19, 2004.

³Grunbaum, J.A., et al. Surveillance Summaries, May 21, 2003. Youth risk behavior surveillance—United States, 2003. Morbidity and Mortality Weekly Report 53(SS-2):1­–96, 2004. More information available at www.cdc.gov/mmwr/preview/mmwrhtml/mm5324a7.htm; accessedOctober 31, 2006.

⁴Wald, A., et al. Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women. Journal of the American Medical Association 285:3100–3106, 2001.

⁵Wald, A., et al. The relationship between condom use and herpes simplex virus acquisition. Annals of Internal Medicine 143:707–713, 2005.

⁶Weström, L., and Eschenbach, D. Pelvic inflammatory disease. In Holmes, K.K., ed. Sexually Transmitted Diseases. 3rd ed. New York, NY: McGraw Hill, 1999, 800–801.

⁷More information available at www.cdc.gov/programs/infect12.htm; accessed October 31, 2006.

⁸CDC, Division of STD Prevention. Sexually Transmitted Disease Surveillance, 1996. Atlanta, GA: U.S. Department of Health and Human Services (HHS), Public Health Service, September 1997. More information available at http://wonder.cdc.gov/wonder/STD/STDD006.PCW.html and at www.cdc.gov/std/Gonorrhea/STDFact-gonorrhea.htm; accessed October 31, 2006.

⁹Turner, K.M., et al. Investigating ethnic inequalities in the incidence of sexually transmitted infections: Mathematical modelling study. Sexually Transmitted Infections 80(5):379–385, 2004.

¹⁰CDC. Sexually Transmitted Disease Surveillance, 2004. Atlanta, GA: HHS, September 2005.

¹¹CDC. The National Plan to Eliminate Syphilis from the United States. Atlanta, GA: HHS, CDC, National Center for HIV, STD, and TB Prevention,1999.

¹²More information available at www.aidsfund.org/naf/partners/partnersDisplay.cfm?PartnerID=2; accessed October 31, 2006.

¹³National Committee for Quality Assurance (NCQA). The State of Health Care Quality: 2005. Washington, DC: NCQA, 2005.

¹⁴Greer, C.E., et al. HPV type distribution and serologic response to HPV virus-like particles in patients with genital warts. Journal of Clinical Microbiology 33:2058–2063, 1995.

¹⁵Munoz, N., et al. HPV and the etiology of human cancer. Vaccine 24(Suppl 3):S1-S10, 2006.

¹⁶CDC. Sexually transmitted diseases treatment guidelines 2002. Morbidity and Mortality Weekly Report 51(No. RR-6):36–37, 2002. More information available at www.cdc.gov/std/treatment/rr5106.pdf; accessed October 31, 2006.

¹⁷CDC. Increases in fluoroquinolone-resistant Neisseria gonorrhoeae among men who have sex with men—United States, 2003, and revised recommendations for gonorrhea treatment, 2004. Morbidity and Mortality Weekly Report 53(16):335–338, 2004. More information available at www.cdc.gov/mmwr/preview/mmwrhtml/mm5316a1.htm; accessed October 31, 2006.

¹⁸CDC. Sexually transmitted diseases treatment guidelines 2002. Morbidity and Mortality Weekly Report 51(No. RR-6):32, 2002. More information available at www.cdc.gov/std/treatment/rr5106.pdf; accessed October 31, 2006.

¹⁹CDC. Expedited Partner Therapy in the Management of Sexually Transmitted Diseases. Atlanta, GA: HHS, 2006, 7. More information available at www.cdc.gov/std/treatment/EPTFinalReport2006.pdf; accessed October 31, 2006.

²⁰CDC. Expedited Partner Therapy in the Management of Sexually Transmitted Diseases. Atlanta, GA: HHS, 2006, 26. More information available at www.cdc.gov/std/treatment/EPTFinalReport 2006.pdf; accessed October 31, 2006.

²¹CDC. Expedited Partner Therapy in the Management of Sexually Transmitted Diseases. Atlanta, GA: HHS, 2006, 8. More information available at www.cdc.gov/std/treatment/EPTFinalReport2006.pdf; accessed October 31, 2006.

²²CDC. Expedited Partner Therapy in the Management of Sexually Transmitted Diseases. Atlanta, GA: HHS, 2006, 32. More information available at www.cdc.gov/std/treatment/EPT FinalReport2006.pdf; accessed October 31, 2006.

²³Golden, M.R., et al. Effect of expedited treatment of sex partners on recurrent or persistent gonorrhea or chlamydial infection. New England Journal of Medicine 352(7):676–685, 2005.

²⁴White, P.J., et al. Patient-Delivered Partner Therapy: When and Where It Should Be Used? Predicting Its Impact in the U.S.A. and U.K. Abstract TO-605. 16th biennial meeting of the International Society for STD Research, July 10–13, 2005, Amsterdam, The Netherlands.

²⁵CDC. Primary and secondary syphilis—United States, 2003–2004. Morbidity and Mortality Weekly Report 55(10):269–273, 2006.

²⁶CDC. Lymphogranuloma venereum among men who have sex with men—Netherlands, 2003–2004. Morbidity and Mortality Weekly Report 53:985–988, 2004.

²⁷Colfax, G., et al. Longitudinal patterns of methamphetamine, popper (amyl nitrite), and cocaine use and high-risk sexual behavior among a cohort of San Francisco men who have sex with men. Journal of Urban Health 82(Suppl 1):i62–i70, 2005.

²⁸Hirshfield, S., et al. Crystal methamphetamine use predicts incident STD infection among men who have sex with men recruited online: A nested case-control study. Journal of Medical Internet Research 6(4):e41, 2004.

²⁹Anderton, J.P., and Valdiserri, R.O. Combating syphilis and HIV among users of Internet chatrooms. Journal of Health Communication 10(7):665–671, 2005.

³⁰Bolding, G., et al. Gay men who look for sex on the Internet: Is there more HIV/STI risk with online partners? AIDS 19(9):961–968, 2005.

³¹CDC. Sexually transmitted diseases treatment guidelines 2002. Morbidity and Mortality Weekly Report 51(RR-6):32, 2002.

³²Schillinger, J.A., et al. Prevalence of Chlamydia trachomatis infection among men screened in 4 U.S. cities. Sexually Transmitted Diseases 32(2):74–77, 2005.

³³Gift, T., et al. The Cost-Effectiveness of Screening Men for Chlamydia to Prevent Pelvic Inflammatory Disease (PID) in Women. Abstract BO2D. National STD Prevention Conference, March 8–11, 2004, Philadelphia, PA.

Note: Documents in PDF format require the Adobe Acrobat Reader®. If you experience problems with PDF documents, please download the latest version of the Reader®.

<<  Previous—Objectives and Subobjectives  |  Table of Contents |  Next—Related Objectives From Other Focus Areas >>